Companies / Oric Pharmaceuticals, Inc. / Activity
Activity — Oric Pharmaceuticals, Inc.
12 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Prudential Financial Inc 13F manager | New | Common stock | $1.22M | +96K | 96,145 0.09% of shares | low |
| Q2 2026 as of | WINTON GROUP Ltd 13F manager | New | Common stock | $898.9K | +83K | 83,000 0.08% of shares | low |
| Q1 2026 as of | Prelude Capital Management, LLC 13F manager | New | Common stock | $583.7K | +46K | 46,070 0.04% of shares | low |
| Q1 2026 as of | Los Angeles Capital Management LLC 13F manager | New | Common stock | $546.5K | +43K | 43,137 0.04% of shares | low |
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | New | Common stock | $393.1K | +36K | 36,296 0.04% of shares | low |
| Q1 2026 as of | Campbell & CO Investment Adviser LLC 13F manager | New | Common stock | $377.8K | +30K | 29,815 0.03% of shares | low |
| Q4 2025 as of | Oxford Asset Management LLP 13F manager | New | Common stock | $160.6K | +20K | 19,638 0.02% of shares | low |
| Q1 2026 as of | Hudson Bay Capital Management LP 13F manager | New | Common stock | $157.0K | +12K | 12,390 0.01% of shares | low |
| Q2 2025 as of | Sanctuary Advisors, LLC 13F manager | New | Common stock | $145.0K | +14K | 14,286 0.01% of shares | low |
| Q2 2023 as of | Barclays PLC 13F manager | New | Common stock | $60.3K | +8K | 7,772 <0.01% of shares | low |
| Q1 2026 as of | MAI Capital Management 13F manager | New | Common stock | $1.9K | +147 | 147 <0.01% of shares | low |
| Q2 2026 as of | Covestor Ltd 13F manager | New | Common stock | $1 | +48 | 48 <0.01% of shares | low |